fda tirzepatide update Drugmakers can keep making off-brand weight-loss drugs as backpedals Is Tirzepatide Legal in 2026?

& Liebscher, I

Across the subgroups of patients with different baseline cardiovascular conditions, mean age ranged from approximately 59 to 67 years, baseline BMI from 33.8 to 36.3 kg/m 2 , and baseline type 2 diabetes prevalence from 25.4% in aortic disease to 50.8% in heart failure, with broadly balanced matching across the individual subgroups (Table 2)

Other investigational uses, such as non-alcoholic steatohepatitis, offer pipeline upside but currently contribute marginal revenue

The Headache Support Patch from PatchAid offers

However, some eating patterns place a greater emphasis on food quality and minimally processed ingredients than on calories alone